EODData

FRA, 5HZ1: HANGZHOU TIGERMED CO. H 1

04 Feb 2026
LAST:

5.700

CHANGE:
 0.10
OPEN:
5.700
HIGH:
5.700
ASK:
0.000
VOLUME:
533
CHG(%):
1.79
PREV:
5.600
LOW:
5.700
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
04 Feb 265.7005.7005.7005.700533
03 Feb 265.6505.6505.6005.60084
02 Feb 265.4505.6005.4005.6000
30 Jan 265.9005.9005.8505.850533
29 Jan 265.4005.4005.3505.350533
28 Jan 265.0505.0504.9805.000533
27 Jan 265.2005.2005.1505.150533
26 Jan 265.3505.3505.3005.300533
23 Jan 265.5505.5505.5005.500533
21 Jan 265.6005.6005.5505.550533

PROFILE

Name:HANGZHOU TIGERMED CO. H 1
About:Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People's Republic of China and internationally. It operates through Clinical Trial Solutions; and Clinical-related and Laboratory Services segments. The company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, decentralized clinical trials, clinical development strategy, site management, medical device/in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services. It also provides medical imaging, pharmacovigilance, medical translation, quality assurance, GMP and medical device consulting, central laboratories, functional services, recruitment management, EDC cloud-based system, and remote follow-up center services; and post-marketing clinical research solutions, such as site identification and selection, central monitoring, project team management, vendor management, and SAS project management services. In addition, the company offers patient recruitment, investment management, medical registration, pharmaceuticals and regulations consulting, drug safety, bioequivalence, and third-party training services, as well as chemistry, management, and controls services. Hangzhou Tigermed Consulting Co., Ltd was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.
Sector:Healthcare
Address:Shengda Science Park, Building A, Hangzhou, China, 310051
Website:https://www.tigermedgrp.com
ISIN:CNE1000040M1

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:47.33 
Forward P/E:12.77 
Price to Sales:0.83 
Price to Book:1.45 
Profit Margin:0.09 
Operating Margin:0.11 
Return on Assets:0.01 
Return on Equity:0.03 
DivYield:0.06 
Div/Share:0.30 
Revenue:793.6M 
EBITDA:128.54M 
Shares:123.13M 
Market Cap:701.81M 

TECHNICAL INDICATORS

MA5:5.621.4%
MA10:5.464.4%
MA20:5.503.7%
MA50:4.7919.0%
MA100:4.8717.1%
MA200:4.5525.2%
STO9:77.78
STO14:77.78
RSI14:48.89
WPR14:-17.65 
ATR:0.19 
Week High:5.903.5%
Week Low:4.9814.5%
Month High:5.903.5%
Month Low:4.8025.2%
Year High:6.4412.9%
Year Low:2.76106.7%

RECENT DIVIDENDS

Date Amount
12 Jun 2025$0.04
07 Jun 2024$0.07
29 May 2024$0.62
25 May 2023$0.07
24 May 2022$0.06